Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study

NCT: NCT01307384 · COMPLETED

NCT IDNCT01307384
StatusCOMPLETED
Start Date2011-03-29
Completion2026-07-17
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multi-center, non-randomized, non-controlled study designed to obtain survival and outcome data on the Continuum Metal on Polyethylene Acetabular System when used in primary total hip arthroplasty.

Frequently Asked Questions

What is Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study?

Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study is a clinical trial registered under NCT01307384. Current status: COMPLETED.

What is the status of NCT01307384?

The current status of NCT01307384 (Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study) is: COMPLETED.

When did Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study start?

Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study started on 2011-03-29.

Related Devices

K243571Trabecular Metal Acetabular Revision System, Acetabular Liners and Constrained LinersZimmer Biomet K161830Zimmer M/L Taper Hip ProsthesisZimmer, Inc. K172767Zimmer Trabecular Metal Reverse Shoulder System, Mini GlenoidZimmer, Inc. K182678Zimmer M/L Taper Hip Prosthesis with Kinectiv Technology MR LabelingZimmer, Inc. K190656Dual Mobility - Longevity and Vivacit-E Polyethylene Hip BearingsZimmer, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑